Aap Implantate AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
aap Implantate AG gives Q1 2014 sales and EBITDA outlook; not to pay FY 2013 dividend
aap Implantate AG:Expects Q1 2014 sales between 6.8 million and 7.0 million euros and EBITDA between 0 and 0.5 million euros.Not to pay FY 2013 dividend (2012: no dividend as well).
Latest Developments for Aap Implantate AG
- aap Implantate AG completes spin off of its non-core business dental
- aap Implantate AG issues FY 2014 Q2 outlook; reaffirms FY 2014 outlook
- aap Implantate AG announces Bruke Seyoum Alemu as company's new Chairman of Management Board and Chief Executive Officer
- aap Implantate AG closing of European Medical Contract Manufacturing B.V. divestment
- Share this
- Digg this